Bryan Johnson, the entrepreneur turned longevity experiment, said on June 30 that he has autoimmune gastritis, an incurable autoimmune disease, according to his post on X cited by The Verge’s Victoria Song.
The diagnosis lands awkwardly for Johnson because his public persona is built around extreme health optimization. Song described him as the internet’s best-known biohacker, a man whose project is to push back against aging through a tightly controlled personal protocol. A Netflix documentary has covered his self-experimentation, according to The Verge.
Johnson’s regimen, as described by Song, includes more than 100 supplements, regular blood draws, wearable tracking, a plant-based diet, and strict sleep habits. It has also included less routine interventions, including a plasma transfer from his teenage son. The whole setup has made Johnson a mascot for the quantified-self wing of wellness: part data project, part performance art, part extremely expensive spreadsheet with a pulse.
Autoimmune gastritis is not a branding problem. According to Song’s description, it is a condition in which the immune system attacks the stomach cells responsible for producing stomach acid. That can impair nutrient absorption and may increase the risk of stomach cancer. Song also noted that the condition is known to be hard to diagnose.
The announcement produced the usual split-screen internet response. Song reported that Johnson received some sympathy after disclosing the illness. He also drew a round of public dunking from wellness influencers who treated the diagnosis as proof that his protocol had failed. One influencer posting under the name organicbunny pointed to Johnson’s reputation for spending heavily on biohacking and immortality, according to The Verge.
That reaction is the part worth inspecting without turning Johnson into a saint or a punchline. His public project invites skepticism. A single person testing an elaborate stack of supplements, devices, diet rules, lab work, and interventions does not prove much about aging for the rest of the species. One-person experiments are noisy by design, especially when the subject is also the promoter.
Still, the diagnosis does not automatically validate Johnson’s critics, either. The facts reported by Song are narrower: Johnson says he has autoimmune gastritis, the disease is incurable, and it affects the stomach’s acid-producing cells. The public record described by The Verge does not establish that his health routine caused the disease, prevented it, worsened it, or failed to detect it earlier.
Johnson’s case exposes a familiar tension in consumer health tech. Wearables, lab tests, supplements, and strict routines promise more control over bodies that remain stubbornly biological. People reach for optimization partly because illness can feel arbitrary and humiliating. Johnson has made that impulse unusually visible, expensive, and easy to mock.
The diagnosis also shows the limit of the dashboard. Tracking sleep, blood markers, diet, and interventions can produce data. It cannot turn a human body into software with a clean changelog and a rollback button.
This story draws on original reporting from The Verge.
